Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Sex Transm Infect. 2018 Jan 29;94(8):578–581. doi: 10.1136/sextrans-2017-053414

Table 1.

Characteristics and Management of Participants with Anorectal Lymphogranuloma Venereum

ID Age Visit Number HIV Anorectal Gonorrhoea Treatment Outcome
1 18 1 Negative Negative Doxycycline 100mg PO BID x 7 days prescribed 120 days after diagnosis Unknown; LTFU
2 19 1 Negative Negative None Unknown; LTFU
3 18 1 Positive Positive Azithromycin 2gm PO x 1 dose prescribed 118 days after diagnosis Cleared infection at next visit 92 days after treatment
4 19 2 Positive Positive Self-prescribed antibiotics Cleared CT at next visit 101 days after diagnosis, still positive for NG and treated with ceftriaxone 1gm IM x 1 dose
5 18 1 Positive Negative Self-prescribed antibiotics Cleared CT at next visit 237 days after diagnosis, newly positive for NG and treated with ceftriaxone 1gm IM x 1 dose
6 26 1 Positive Negative Doxycycline 100mg PO BID x 7 days prescribed 149 days after diagnosis Cleared infection at next visit 91 days after treatment
7 30 1 Positive Negative Doxycycline 100mg PO BID x 7 days prescribed 147 days after diagnosis Cleared infection at next visit 181 days after treatment

Abbreviations: BID, bis in die (two times per day); CT, Chlamydia trachomatis; IM, intramuscular; HIV, human immunodeficiency virus; LTFU, lost to follow-up; NG, Neisseria gonorrhoeae; PO, per os (by mouth). The date of swab collection was used as the diagnosis date for the purpose of calculating days from diagnosis to treatment. Participants were re-tested for STIs at their next scheduled visit after treatment.